McNeill Jonathan — SEC insider filings

SEC reporting owner CIK 1824673. 31 insider filings on record with FilingPulse; latest filed 2026-09-18.

Transaction summary — filings shown

Covers all 31 filings on record, filed 2020-09-18 to 2026-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Dyne Therapeutics, Inc. (DYN)Chief Business Officer27—34 legs · 250,382 sh · $5,628,34232
CRESCENT BIOPHARMA, INC. (CBIO)President and COO4—3 legs · 25,119 sh · $446,9114

Insider filings — McNeill Jonathan

FiledFormIssuerReported transactionsSource
2026-09-184CRESCENT BIOPHARMA, INC. (CBIO)Sale (S): 731 @ $17.90 · Sale (S): 3,839 @ $16.71EDGAR
2026-06-234CRESCENT BIOPHARMA, INC. (CBIO)Sale (S): 20,549 @ $17.99EDGAR
2025-12-174CRESCENT BIOPHARMA, INC. (CBIO)Grant/award (A): 19,507 · Grant/award (A): 6,000 · Grant/award (A): 78,029 (derivative) @ $0EDGAR
2025-12-104CRESCENT BIOPHARMA, INC. (CBIO)Grant/award (A): 172,836 (derivative) @ $0EDGAR
2024-08-204Dyne Therapeutics, Inc. (DYN)Sale (S): 2,400 @ $45.01 · Sale (S): 305 @ $46EDGAR
2024-06-114Dyne Therapeutics, Inc. (DYN)Sale (S): 1,823 @ $31.34EDGAR
2024-05-174Dyne Therapeutics, Inc. (DYN)Sale (S): 2,279 @ $28.20 · Sale (S): 495 @ $28.59EDGAR
2024-04-044Dyne Therapeutics, Inc. (DYN)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2024-03-134Dyne Therapeutics, Inc. (DYN)Option exercise (M): 86,159 @ $5.54 · Option exercise (M): 3,841 @ $5.54 · Sale (S): 34,663 @ $25.46 · Sale (S): 54,648 @ $26.72 · Sale (S): 689 @ $27.31 · Option exercise (M): 17,825 @ $5.54 · +5 moreEDGAR
2024-03-114Dyne Therapeutics, Inc. (DYN)Sale (S): 2,434 @ $25.85EDGAR
2024-03-014Dyne Therapeutics, Inc. (DYN)Option exercise (M): 4,268 @ $0.73 · Sale (S): 4,268 @ $27.50 · Option exercise (M): 24,260 @ $0.73 · Sale (S): 14,103 @ $28.25 · Sale (S): 8,715 @ $29.06 · Sale (S): 1,442 @ $29.70 · +2 moreEDGAR
2024-01-264Dyne Therapeutics, Inc. (DYN)Option exercise (M): 20,000 @ $0.73 · Sale (S): 19,822 @ $24.52 · Sale (S): 178 @ $25.14 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2024-01-044Dyne Therapeutics, Inc. (DYN)Sale (S): 11,900 @ $13.10 · Option exercise (M): 17,991 @ $0.73 · Sale (S): 7,691 @ $18.34 · Sale (S): 10,300 @ $19.03 · Option exercise (M): 2,009 @ $0.73 · Sale (S): 2,009 @ $18.04 · +2 moreEDGAR
2023-12-124Dyne Therapeutics, Inc. (DYN)Sale (S): 1,245 @ $10.72EDGAR
2023-11-164Dyne Therapeutics, Inc. (DYN)Grant/award (A): 96,158 @ $0 · Grant/award (A): 37,445 (derivative) @ $0EDGAR
2023-09-204Dyne Therapeutics, Inc. (DYN)Sale (S): 1,261 @ $9.41EDGAR
2023-09-134Dyne Therapeutics, Inc. (DYN)Sale (S): 1,266 @ $10.41EDGAR
2023-06-144Dyne Therapeutics, Inc. (DYN)Sale (S): 1,000 @ $13 · Sale (S): 1,259 @ $12.43EDGAR
2023-03-154Dyne Therapeutics, Inc. (DYN)Sale (S): 1,000 @ $13 · Sale (S): 1,209 @ $13.33EDGAR
2023-01-234Dyne Therapeutics, Inc. (DYN)Option exercise (M): 10,000 @ $0.73 · Sale (S): 10,000 @ $14.03 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2023-01-114Dyne Therapeutics, Inc. (DYN)Sale (S): 30,150 @ $11.57EDGAR
2022-12-134Dyne Therapeutics, Inc. (DYN)Grant/award (A): 40,000 @ $0 · Sale (S): 472 @ $10.87 · Grant/award (A): 63,000 (derivative) @ $0EDGAR
2022-09-214Dyne Therapeutics, Inc. (DYN)Disposition to issuer (D): 1,246 @ $13.70EDGAR
2022-09-154Dyne Therapeutics, Inc. (DYN)Disposition to issuer (D): 494 @ $14.05EDGAR
2022-07-064Dyne Therapeutics, Inc. (DYN)Grant/award (A): 21,666 (derivative) @ $0EDGAR
2022-06-154Dyne Therapeutics, Inc. (DYN)Disposition to issuer (D): 504 @ $4.95EDGAR
2022-03-144Dyne Therapeutics, Inc. (DYN)Sale (S): 481 @ $8.73EDGAR
2021-12-144Dyne Therapeutics, Inc. (DYN)Grant/award (A): 25,311 @ $0 · Grant/award (A): 37,967 (derivative) @ $0EDGAR
2021-09-224Dyne Therapeutics, Inc. (DYN)Sale (S): 545 @ $15.61 · Sale (S): 729 @ $16.11EDGAR
2021-07-134Dyne Therapeutics, Inc. (DYN)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2020-09-184Dyne Therapeutics, Inc. (DYN)Grant/award (A): 17,012 @ $0 · Grant/award (A): 52,787 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1824673 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs